Mackay Shields LLC’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,251
| Closed | -$2.06M | – | 350 |
|
|
2022
Q1 | $2.06M | Sell |
7,251
-287
| -4% | -$81.5K | 0.02% | 559 |
|
|
2021
Q4 | $2.84M | Sell |
7,538
-152
| -2% | -$57.3K | 0.02% | 497 |
|
|
2021
Q3 | $3.17M | Sell |
7,690
-455
| -6% | -$188K | 0.03% | 438 |
|
|
2021
Q2 | $3.01M | Sell |
8,145
-23,706
| -74% | -$8.77M | 0.03% | 457 |
|
|
2021
Q1 | $9.23M | Sell |
31,851
-32,568
| -51% | -$9.44M | 0.07% | 303 |
|
|
2020
Q4 | $16.1M | Sell |
64,419
-5,600
| -8% | -$1.4M | 0.11% | 199 |
|
|
2020
Q3 | $15.9M | Sell |
70,019
-149
| -0.2% | -$33.7K | 0.11% | 201 |
|
|
2020
Q2 | $12.2M | Sell |
70,168
-32,312
| -32% | -$5.63M | 0.1% | 241 |
|
|
2020
Q1 | $12.9M | Sell |
102,480
-18,678
| -15% | -$2.36M | 0.12% | 195 |
|
|
2019
Q4 | $18.5M | Buy |
121,158
+51,844
| +75% | +$7.92M | 0.13% | 194 |
|
|
2019
Q3 | $9.18M | Buy |
69,314
+19,679
| +40% | +$2.6M | 0.06% | 357 |
|
|
2019
Q2 | $7.04M | Sell |
49,635
-73,278
| -60% | -$10.4M | 0.05% | 426 |
|
|
2019
Q1 | $17.9M | Sell |
122,913
-1,788
| -1% | -$260K | 0.13% | 197 |
|
|
2018
Q4 | $14.1M | Buy |
+124,701
| New | +$14.1M | 0.11% | 224 |
|
|
2018
Q3 | – | Sell |
-46,182
| Closed | -$5.18M | – | 1168 |
|
|
2018
Q2 | $5.18M | Buy |
46,182
+33,781
| +272% | +$3.79M | 0.04% | 464 |
|
|
2018
Q1 | $1.32M | Buy |
+12,401
| New | +$1.32M | 0.01% | 912 |
|